SV-BR-1-GM, a Clinically Effective GM-CSF-Secreting Breast Cancer Cell Line, Expresses an Immune Signature and Directly Activates CD4+ T Lymphocytes-Reference-Cited by-同舟云学术

SV-BR-1-GM, a Clinically Effective GM-CSF-Secreting Breast Cancer Cell Line, Expresses an Immune Signature and Directly Activates CD4+ T Lymphocytes

Published:2018-05-15 Issue: Volume:9 Page:
ISSN:1664-3224
Container-title:Frontiers in Immunology
language:
Short-container-title:Front. Immunol.

Author:

Lacher Markus D.,Bauer Gerhard,Fury Brian,Graeve Sanne,Fledderman Emily L.,Petrie Tye D.,Coleal-Bergum Dane P.,Hackett Tia,Perotti Nicholas H.,Kong Ying Y.,Kwok William W.,Wagner Joseph P.,Wiseman Charles L.,Williams William V.

Publisher

Frontiers Media SA

Subject

Immunology,Immunology and Allergy

Reference110 articles.

1. Antibody-modified T cells: CARs take the front seat for hematologic malignancies;Maus;Blood,2014

2. Chimeric antigen receptor T cells for sustained remissions in leukemia;Maude;N Engl J Med,2014

3. Bispecific antibodies;Kontermann;Drug Discov Today,2015

4. A pilot trial using lymphocytes genetically engineered with an NY-ESO-1-reactive T-cell receptor: long-term follow-up and correlates with response;Robbins;Clin Cancer Res,2015

5. Durable complete response from metastatic melanoma after transfer of autologous T cells recognizing 10 mutated tumor antigens;Prickett;Cancer Immunol Res,2016

Cited by 19 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Results of a phase I/IIa trial of SV-BR-1-GM inoculation with low-dose cyclophosphamide and interferon alpha (Bria-IMT) in metastatic breast cancer;Human Vaccines & Immunotherapeutics;2024-08-20

2. Counteractive effects of extracts of Mangifera indica on testes of Wistar Rat exposed to cyclophosphamide;Heliyon;2023-09

3. The use of RNA-based treatments in the field of cancer immunotherapy;Molecular Cancer;2023-07-07

4. Regression of Breast Cancer Metastases Following Treatment with Irradiated SV-BR-1-GM, a GM-CSF Overexpressing Breast Cancer Cell Line: Intellectual Property and Immune Markers of Response;Recent Patents on Anti-Cancer Drug Discovery;2023-05

5. Cationic Nanoparticle-Stabilized Vaccine Delivery System for the H9N2 Vaccine to Promote Immune Response in Chickens;Molecular Pharmaceutics;2023-02-16